1The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med,1993,329:977-986.
2UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998,352.:837-853.
3Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complica tions in Japanese patients with non-insulin-dependent diabetes mellitus; a randomized prospective 6-year study. Diabetes Res Clin Pratt,1995,28 ; 103-117.
4Turner RC, Milns H, Neil HA, et al. Risk factors for coronary artery disease in non insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS.. 23). BMJ, 1998, 316:823-828.
5The ADVANCE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med,2008,358:2560 2572.
6The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med,2008,358.-2545-2559.
7Holman RR, Sanjoy KP, Bethel MA, et al. 10 Year Follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359 : 1577-1589.
8Bakris GL, Ruilope LM, McMorn SO, et al. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. J Hypertens, 2006,24:2047-2055.
9Mogensen CE, Neldam S, Tikkanen I, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ, 2000,321 :1440-1444.
10Monnier L, Colette C, Monnier L. Contributions of fasting and postprandial glucose to hemoglobin Ale. Endocr Pract, 2006,12 Suppl 1:42-46.
